ZURICH, Feb 11 (Reuters) - German specialty chemicals maker Evonik said on Thursday it is investing in the short-term expansion of production of lipids to be used to in BioNTech and Pfizer’s COVID-19 vaccine.
“We are ... doing everything possible to supply our partners with the critical lipids they need,” Christian Kullmann, chairman of Evonik’s executive board, said in a statement. (Reporting by John Miller; editing by Thomas Seythal)
我们的标准: 汤森路透“信任原则”